CSF tau biomarkers change later in the pathophysiological process compared to CSF Aβ1-42 [19, 20] and CSF tau is stronger correlated with cognitive decline than Aβ1-42 [20, 21]. The gene discussed is MAPT; the disease is Mental deterioration.